Insider Trading Alert - DV, ANDE And THC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, May 23, 2014, 112 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $90.00 to $7,463,228.50.

Highlighted Stocks Traded by Insiders:

DeVry Education Group (DV) - FREE Research Report

Riehs Steven, who is President, K-12, International at DeVry Education Group, sold 700 shares at $41.91 on May 23, 2014. Following this transaction, the President, K-12, International owned 18,986 shares meaning that the stake was reduced by 3.56% with the 700-share transaction.

The shares most recently traded at $42.37, up $0.46, or 1.09% since the insider transaction. Historical insider transactions for DeVry Education Group go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 61,638
  • 24-Week # shares sold: 114,490

The average volume for DeVry Education Group has been 607,700 shares per day over the past 30 days. DeVry Education Group has a market cap of $2.7 billion and is part of the services sector and diversified services industry. Shares are up 18.48% year-to-date as of the close of trading on Friday.

DeVry Education Group Inc. provides educational services worldwide. The stock currently has a dividend yield of 0.81%. The company has a P/E ratio of 29.2. Currently, there are 3 analysts who rate DeVry Education Group a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DV - FREE

TheStreet Quant Ratings rates DeVry Education Group as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income and disappointing return on equity. Get the full DeVry Education Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Andersons (ANDE) - FREE Research Report

Conrad Nicholas C, who is VP Finance & Treasurer at Andersons, bought 965 shares at $45.03 on May 23, 2014. Following this transaction, the VP Finance & Treasurer owned 10,995 shares meaning that the stake was boosted by 9.62% with the 965-share transaction.

The shares most recently traded at $46.30, up $1.27, or 2.74% since the insider transaction. Historical insider transactions for Andersons go as follows:

  • 4-Week # shares bought: 965
  • 4-Week # shares sold: 4,098
  • 12-Week # shares bought: 965
  • 12-Week # shares sold: 7,629
  • 24-Week # shares bought: 965
  • 24-Week # shares sold: 23,027

The average volume for Andersons has been 292,900 shares per day over the past 30 days. Andersons has a market cap of $1.3 billion and is part of the consumer goods sector and food & beverage industry. Shares are down 23.19% year-to-date as of the close of trading on Friday.

The Andersons, Inc. is engaged in the grain, ethanol, plant nutrient, railcar leasing, turf and cob products, and consumer retailing businesses. It operates in six segments: Grain, Ethanol, Rail, Plant Nutrient, Turf & Specialty, and Retail. The stock currently has a dividend yield of 0.96%. The company has a P/E ratio of 12.9. Currently, there are no analysts who rate Andersons a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ANDE - FREE

TheStreet Quant Ratings rates Andersons as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, reasonable valuation levels and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Andersons Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Tenet Healthcare (THC) - FREE Research Report

Fetter Trevor, who is CEO and President at Tenet Healthcare, sold 35,394 shares at $47.52 on May 23, 2014. Following this transaction, the CEO and President owned 963,790 shares meaning that the stake was reduced by 3.54% with the 35,394-share transaction.

The shares most recently traded at $47.52, up $0.00, or 0.01% since the insider transaction. Historical insider transactions for Tenet Healthcare go as follows:

  • 4-Week # shares bought: 6,250
  • 4-Week # shares sold: 22,000
  • 12-Week # shares bought: 6,250
  • 12-Week # shares sold: 35,624
  • 24-Week # shares bought: 6,250
  • 24-Week # shares sold: 35,624

The average volume for Tenet Healthcare has been 2.0 million shares per day over the past 30 days. Tenet Healthcare has a market cap of $4.7 billion and is part of the health care sector and health services industry. Shares are up 13.72% year-to-date as of the close of trading on Friday.

Tenet Healthcare Corporation, an investor-owned health care services company, primarily operates acute care hospitals and related health care facilities in the United States. Currently, there are 7 analysts who rate Tenet Healthcare a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on THC - FREE

TheStreet Quant Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, disappointing return on equity and poor profit margins. Get the full Tenet Healthcare Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

Billionaire Investor Tim Draper Explains Why Bitcoin Will Hit $250,000 in 2022

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

M&A Trends Still on Investors' Minds Despite Worries Over Tariffs -- ICYMI

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods

Dow Falls as U.S. Imposes Tariffs on $50 Billion of Chinese Goods

General Motors Spikes on Report It's Considering Listing Shares of Cruise Unit

General Motors Spikes on Report It's Considering Listing Shares of Cruise Unit